Life Science Consulting Translating Innovation into Market Success
Our life science consulting expertise extends to medical device, pharmaceutical and biotech companies involved in technology, medication and biologic products to cure, treat, and prevent a variety of diseases. The opportunities to capture revenues in these markets are significant. In 2022, the global market for medical devices was $489B USD projected to grow to $719B USD by 2029 at a CAGR of 5.5% during the forecast timeline. The pharmaceutical market is triple that size with a CAGR of 9.1%. Patient care and management require continued commitment and innovation development, especially as the population profile of most countries is aging. According to the World Health Organization, by 2030, one in every six people on the planet will be 60 years or older, an age when more healthcare services are required.
We work with life science and medical technology companies who create life changing innovation to allow people to live longer, healthier and more productive lives. companies develop, manufacture, distribute and support the technologies, devices, equipment, diagnostic tests, and health information systems that are transforming health care through earlier disease detection, less-invasive procedures, and more effective treatments.
The clinical areas of medical technology we are involved in include neurostimulation, oncology, orthobiologics, minimally invasive surgery, robotic-assisted technology, orthopedics including spine, cardiovascular, gastroenterology, dermatology, wound closure, women’s and men’s health, energy-based therapeutics and diagnostics and others. Strategy Inc. also is involved in mobile health applications and AI driven technologies.
Who we are
As life science consultants, Strategy Inc. works with innovators across a broad spectrum of medical companies to address challenges and stay ahead of the always-dynamic healthcare landscape. Our life science consultants, use their expert knowledge to provide insight to translate innovation into market success. The experience and proven expertise of Strategy Inc. ensures that clients bringing new technology to market will succeed with solutions changing the standard of care. A clear understanding of market trends, pricing and positioning strategies driven by value-based care ensures products will lead to market expectations. If technology is at the leading edge of innovation changing the paradigm of care, Strategy Inc. is usually involved.
Strategy Inc. also specializes in helping innovators bring their medical technologies to US markets, combining an understanding of clinical landscapes and healthcare facility purchasing practices with strategic thinking.
How we help?
For new market entrants, either from emerging technologies or entities outside the US seeking US commercialization, Strategy Inc. can help develop identify, prioritize and target key market segments with a go-to-market strategy. A multi-stage process, the go-to-market strategy is built on first identifying necessary market diligence to support strategic decision making in the commercialization process, followed by framing the sales and marketing plans. Experience has shown that a strategy built on focused diligence with advisement supported by dedicated research has the highest potential for success.
Diligence components of a go-to-market strategy include, but are not limited to:
- Voice of the Customer: Clinical Adoption Analysis
- Prioritization of Key Market Segments
- Competitive Landscape and Positioning Strategy
- Comparative Pricing Analysis
- Risk Assessment and Mitigation Mapping
At Strategy Inc. experience has confirmed that many of our service offerings are paramount to developing a framework for a successful commercialization launch strategy.
Your investors and executive management alike require confirmation of market opportunity, projected adoption, competitive landscape and risk analysis for defensible revenue projections. For this reason, essential diligence collected from both primary and robust secondary data will construct the blueprint for a strong foundation.
Understanding the current and anticipated future markets where your medical technology will compete, target market options, and anticipated developments and risk hurdles ensures comprehension and confidence of the innovation’s adopted trajectory. This is an area where the best practice due diligence yield cost effective information that is the basis for vetted decision making.
- Market due diligence to validate target market and adoption forecasting
- Ensure commitment from anticipated end users to accelerate time to positive cash flow with a confirmed market strategy
- Market size and confirmed penetration rates for preclinical technology is the cornerstone to increased valuation
- Third party valuation by experienced Medtech financial advisors
- Externally validated analysis resonates with sophisticated investors who rarely give credence to internally generated valuation
- Scope of direct and indirect competitors, both current and future
- Grasp the complete landscape for your value proposition to prioritize the open space most receptive to accelerated adoption
- Pipeline technology evaluation considering market size, commercialization timeline and risk and other external factors to summarize
- Prioritize between divergent technologies, (med device, biologics, or pharmaceuticals) to focus resources first on products with the greatest potential
Client Testimonials
Strategy Inc. works with clients, such as the ones shown in the testimonials below. Clients who are pleased with the outcomes of their due diligence have kindly provided testimonials. Review to see what types of projects have been completed, that are close to what you need to have completed. For example, do you need a market assessment, or competitive analysis? Perhaps you need to identify Key Opinion leaders to support your preclinical innovation? Are you in the process of bringing your technology to the US, and seek leading clinicians who understand the value of your technology. Review several of the testimonials for insight into the quality of work that Strategy Inc. delivers.
“Strategy Inc. has worked with a number of my companies on a variety of important strategic projects. I have found […]
“Strategy Inc. helped us to get a handle on an emerging therapeutic solution that provides a complete paradigm shift – […]
“Strategy Inc. worked with us on the Valuation and due diligence for an emerging stage innovative medical device technology. The […]
“Prior to allocating additional resources for expansion of our product portfolio, Strategy Inc. performed a worldwide market due diligence analysis […]
“As Senior Manager, Marketing & Commercialization at OrthoXel I commissioned Nancy Patterson and Strategy Inc. to run a deep intensive […]
“We hired Strategy Inc. to support our US Market Launch and identify KOLs with a lengthy list of criteria in […]
“We hired Strategy Inc. to deliver a Competitive Analysis with a deep dive into MAUDE data and publications. Strategy Inc.’s […]
“We hired Strategy Inc. to identify US Key Opinion leaders in Ophthalmology, to support our fund raising efforts and calibrate […]
“Strategy Inc. was able to perform a market analysis and technology assessment that permitted our company to monetize our intellectual […]
“We used Strategy Inc. to perform a Business Analysis and Optimal Market Action Plan for a paradigm changing supply chain […]
“In working with Strategy Inc. on marketing claims analysis and market research, we found that their processes and hard work […]
"We hired Strategy Inc. to support a Clinical Market Analysis for a wound healing combination innovation funded through a significant […]
“The highly professional, structured and focused process of competitive analysis conducted by Strategy Inc. contributed significantly and brought certainty to […]
“Strategy Inc. performed a business analysis for several of our biologic emerging technologies delivering a US market strategy. The due […]
“Strategy Inc. performed a TechSelect Analysis on eight of our developing technologies at LA BioMed, the Los Angeles Biomedical Research […]
“Strategy Inc. identified, validated and provided introductions to Key Opinion Leaders for the formation of our Scientific Advisory Board to […]
“Strategy Inc. researched and then introduced us to a broad spectrum of Key Opinion Leaders for the formation of our […]
“Strategy Inc. conducted several valuable medical device assessments that were critical in our evaluation of new project proposals. They provided […]
“Strategy Inc. assisted our company with the development of an Investor Presentation and a Valuation Top Line clarifying the value […]